CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$50.50 +0.62 (+1.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) EV to CFO (2019 - 2022)

Updated

CRISPR Therapeutics AG's (CRSP) EV to CFO was 5.23 for Q1 2022, down 18.5% from the prior quarter.

Analysis

CRISPR Therapeutics AG (CRSP) EV to CFO (2019 - 2022) Analysis & Trends

Over the twelve months ended Mar 31, 2022, CRISPR Therapeutics AG's EV to CFO came in at -9.54; for FY2021, it came in at 6.41.

  • By year, EV to CFO came in at 48.66 in FY2019.
  • The Q1 2022 figure ranks as the lowest quarterly EV to CFO in data going back to Q3 2019.
  • Per Business Quant data, the three quarters before Q1 2022 came in at 6.41 (Q4 2021), 11.18 (Q3 2021) and 17.70 (Q2 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 CRISPR Therapeutics AG 4.88 Bn -3.82 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 5.23
Dec 31, 2021 6.41
Sep 30, 2021 11.18
Jun 30, 2021 17.70
Jun 30, 2020 65.99
Mar 31, 2020 35.09
Dec 31, 2019 48.66
Sep 30, 2019 65.49
API Access

CRISPR Therapeutics AG EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=CRSP&period=max&api_key=YOUR_API_KEY